Bad analogy. ABBV's Humira IP includes more than 100 US patents, of which ABBV asserted 61 patents against AMGN in their litigation that ended up being settled.
The Lovenox patent case involved only one or two patents.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”